CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Viralgen annonce un plan de succession pour son PDG

Neutral
AI Analysis

Summary

Viralgen, an AAV gene therapy CDMO and subsidiary of AskBio, announced a succession plan for its CEO. Further details were not included in the available excerpt.

Outcome Details

CEO succession plan announced; details not provided in the available text

Importance:4/10
Sentiment:
0.00
management changeCEO successionCDMOAAVgene therapymanufacturing

Read the original article

Published by PR Newswire Biotech on October 19, 2026 2:54 PM

Read Original